The remaining big questions in transcatheter tricuspid valve intervention

Rebecca Hahn, Anita Asgar and Scott Lim discuss where management and treatment of tricuspid valve diseases stand today.

Even if the subject has finally found its place, a number of questions remain unanswered and deserve to be addressed: Who are the patients that should be treated with transcatheter devices? Are there patients that are too sick to be treated with such devices? In the not-too-distant future, will there be an algorithm for choosing the best device for any given patient?

Follow this round table to find out what our experts feel about these different challenges, backed up by the results of the latest clinical trials.

This interview was filmed at PCR London Valves 2023: see more videos here.